Elysia-Raytest SA is pleased to announce that they have entered into a strategic agreement with EDH Nuclear Medicine and Healthcare Services that makes them our authorized distributor and support partner for selected countries.
Radioprotech has a large range of lead shielding products from ShieldedHot Cells to syringe protectors. Its range will be a good complement to the Elysia-Raytest portfolio in Nuclear Medicine and Radiotherapy.
Elysia S.A. ranked the number 37 fastest-growing company on Deloitte 2019 Technology Fast 500 EMEA list !
Percent revenue growth 2858%, attributed to Healthcare and Life Sciences.
Angleur, 15/11/2019 - Elysia has won Deloitte’s 2019 Technology Fast 50 award. The award was given to Elysia based on its percentage of growth in turnover during the last four years. The announcement was made at the Technology Fast 50 Awards Ceremony on 14 November 2019.
For its site in Straubenhardt (Germany), Elysia-raytest GmbH is currently looking for an:
FIELD SERVICE ENGINEER (GE-EN) (M/F/D).
For its head office in Angleur (Liège), ELYSIA S.A. is currently looking for an:
APPLICATION SPECIALIST IN RADIOCHEMISTRY (EN-FR) (M/F).
We are looking for PhD fellows in Organic Chemistry / Radiopharmaceutical Chemistry at Elysia-Raytest and the Cyclotron Research Centre (CRC) of the University of Liege (BE). You will find more information hereafter.
The Rad4 Med is The Belgian Network for Radiation Applications in Healthcare.
Small deal for IBA, huge step for Elysia
raytest and Elysia - A strong partnership serving the Nuclear Medicine and PET market
Elysia, the start-up with wings
Elysia, the start-up that has become a world leader
Article in the CCI Mag' Liège-Verviers of November 2016 (p.47)